GNMK GenMark Diagnostics, Inc. Stock Quote

GNMK [NASD]

Index	-	P/E	-	EPS (ttm)	-0.41	Insider Own	3.60%	Shs Outstand	71.10M	Perf Week	-5.46%
Market Cap	1.47B	Forward P/E	-	EPS next Y	-0.07	Insider Trans	-19.48%	Shs Float	68.45M	Perf Month	45.68%
Income	-25.20M	PEG	-	EPS next Q	-0.02	Inst Own	98.73%	Short Float	10.33%	Perf Quarter	54.06%
Sales	148.70M	P/S	9.88	EPS this Y	9.40%	Inst Trans	5.93%	Short Ratio	7.00	Perf Half Y	29.99%
Book/sh	1.32	P/B	14.81	EPS next Y	70.80%	ROA	-15.90%	Target Price	21.00	Perf Year	440.06%
Cash/sh	1.83	P/C	10.70	EPS next 5Y	-	ROE	-48.20%	52W Range	3.36 - 23.59	Perf YTD	33.90%
Dividend	-	P/FCF	-	EPS past 5Y	2.30%	ROI	-51.50%	52W High	-17.13%	Beta	3.08
Dividend %	-	Quick Ratio	3.80	Sales past 5Y	23.50%	Gross Margin	38.80%	52W Low	481.85%	ATR	1.49
Employees	437	Current Ratio	4.30	Sales Q/Q	103.80%	Oper. Margin	-11.90%	RSI (14)	59.25	Volatility	7.94% 8.49%
Optionable	Yes	Debt/Eq	0.75	EPS Q/Q	77.60%	Profit Margin	-17.00%	Rel Volume	1.95	Prev Close	18.80
Shortable	Yes	LT Debt/Eq	0.75	Earnings	Feb 25 AMC	Payout	-	Avg Volume	1.01M	Price	19.55
Recom	1.90	SMA20	9.85%	SMA50	22.41%	SMA200	38.13%	Volume	1,967,089	Change	3.99%

Aug-05-20

Reiterated

Needham

Buy

$19 → $22

Jul-08-20

Reiterated

Needham

Buy

$15 → $19

May-05-20

Reiterated

Needham

Buy

$11 → $15

Feb-11-20

Downgrade

Raymond James

Outperform → Mkt Perform

Dec-11-19

Downgrade

JP Morgan

Overweight → Neutral

Feb-22-19

Reiterated

Needham

Buy

$12

Nov-03-17

Reiterated

Needham

Buy

$15 → $11

Nov-03-17

Downgrade

Raymond James

Outperform → Mkt Perform

Sep-18-17

Initiated

BofA/Merrill

Buy

$13

Sep-13-17

Reiterated

Needham

Buy

$17 → $15

Aug-31-17

Resumed

BTIG Research

Buy

$13

Jun-13-17

Reiterated

Needham

Buy

$16 → $17

Jan-24-17

Reiterated

Needham

Buy

$13 → $15

Feb-24-16

Reiterated

Needham

Buy

$13 → $11

Oct-28-15

Reiterated

Needham

Buy

$16 → $13

May-06-15

Reiterated

Canaccord Genuity

Buy

$16 → $14

Apr-17-15

Reiterated

Canaccord Genuity

Buy

$17 → $16

Dec-19-13

Initiated

Needham

Buy

$17

Aug-08-13

Reiterated

Canaccord Genuity

Buy

$18 → $14

Apr-15-13

Reiterated

Canaccord Genuity

Buy

$14 → $18

Feb-25-21 04:05PM	GenMark Diagnostics Reports Fourth Quarter and Full Year 2020 Results GlobeNewswire
02:30PM	GenMark Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Feb-22-21 04:05PM	GenMark ePlex® RP2 Panel Predicted to Detect Known SARS-CoV-2 Variants Currently in Circulation Based on in silico Analysis GlobeNewswire
Feb-16-21 05:35PM	GenMark Diagnostics to Participate in the Cowen 41st Annual Health Care Conference GlobeNewswire
04:03PM	Study Highlights Potential Clinical Value of ePlex® Blood Culture ID Panels GlobeNewswire
Feb-11-21 04:17PM	GenMark Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021 GlobeNewswire +33.16%
11:56AM	Why GenMark Diagnostics Stock Is Soaring Today Motley Fool
Jan-11-21 04:08PM	GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2020 GlobeNewswire -6.92%
Dec-29-20 02:38AM	Is GenMark Diagnostics (NASDAQ:GNMK) Weighed On By Its Debt Load? Simply Wall St.
Dec-28-20 04:05PM	GenMark Diagnostics to Participate in Upcoming Investor Conferences GlobeNewswire
Dec-22-20 01:48PM	Genmark Diagnostics Shows Market Leadership With Jump To 91 RS Rating Investor's Business Daily
Nov-05-20 04:05PM	GenMark Diagnostics to Participate in the Canaccord Virtual MedTech & Diagnostics Forum GlobeNewswire
Oct-30-20 07:53AM	GenMark Diagnostics, Inc. (NASDAQ:GNMK) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates Simply Wall St.
Oct-29-20 02:03AM	GenMark Diagnostics Inc (GNMK) Q3 2020 Earnings Call Transcript Motley Fool +7.94%
Oct-28-20 04:05PM	GenMark Diagnostics Reports Third Quarter 2020 Results GlobeNewswire
02:30PM	GenMark Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Oct-21-20 12:32PM	GenMark Diagnostics (GNMK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Oct-14-20 05:20PM	GenMark Diagnostics to Report Third Quarter 2020 Financial Results on October 28, 2020 GlobeNewswire
Oct-09-20 09:59AM	Dow Jones Today, Stocks Climb Toward October Surprise; Deal Chatter Ignites Xilinx Investor's Business Daily
04:37AM	GenMark Pops 13% On Very Strong 3Q, FDA Emergency Clearance SmarterAnalyst
Oct-08-20 04:05PM	GenMark Diagnostics ePlex® Respiratory Pathogen Panel 2 (RP2) Receives EUA from FDA GlobeNewswire -5.36%
04:03PM	GenMark Diagnostics Provides Preliminary Financial Results for Third Quarter 2020 GlobeNewswire
Sep-29-20 10:50AM	Hedge Funds Are Still Plowing Into GenMark Diagnostics, Inc (GNMK) Insider Monkey
Sep-22-20 07:00AM	Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments PR Newswire
Sep-16-20 10:08AM	Are Options Traders Betting on a Big Move in GenMark Diagnostics (GNMK) Stock? Zacks
Sep-14-20 04:05PM	GenMark Diagnostics ePlex® Respiratory Pathogen Panel 2 (RP2) achieves CE Mark GlobeNewswire
Sep-07-20 01:53PM	Breakeven On The Horizon For GenMark Diagnostics, Inc. (NASDAQ:GNMK) Simply Wall St.
Aug-27-20 12:39PM	Why Co-Diagnostics, GenMark, Luminex, and Opko Stocks Are Sinking Today Motley Fool -12.77%
Aug-17-20 08:00AM	GenMark Diagnostics Announces Submission of Emergency Use Authorization for its eSensor® SARS-CoV-2 Test GlobeNewswire
Aug-05-20 02:01AM	GenMark Diagnostics Inc (GNMK) Q2 2020 Earnings Call Transcript Motley Fool
Aug-04-20 05:20PM	Recap: GenMark Diagnostics Q2 Earnings Benzinga
04:05PM	GenMark Diagnostics Reports Second Quarter 2020 Results GlobeNewswire
Jul-29-20 04:05PM	GenMark Diagnostics to Participate in Upcoming Investor Conferences GlobeNewswire
Jul-24-20 10:15AM	Why A Covid-19 Vaccine Won't Halt Feverish Demand For Coronavirus Tests Investor's Business Daily -6.30%
Jul-22-20 12:22PM	Is GenMark Diagnostics' (NASDAQ:GNMK) Share Price Gain Of 186% Well Earned? Simply Wall St.
11:30AM	Has GenMark Diagnostics (GNMK) Outpaced Other Medical Stocks This Year? Zacks
Jul-21-20 04:05PM	GenMark Diagnostics to Report Second Quarter 2020 Financial Results on August 4, 2020 GlobeNewswire
04:05PM	GenMark Diagnostics to Report Second Quarter 2020 Financial Results on August 4, 2020 GlobeNewswire
Jul-14-20 06:56AM	GenMark's Shares March Higher, Can It Continue? Zacks
Jul-09-20 09:54PM	GenMark Diagnostics (GNMK) Stock Is a Winner, But How Much Higher Can It Go? SmarterAnalyst
Jul-08-20 04:18PM	Covid Report: Coronavirus Test Maker GenMark Diagnostics Jumps On Sales Beat Investor's Business Daily +20.97%
12:07PM	Why GenMark Diagnostics Stock Is Soaring Today Motley Fool
07:31AM	The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy Benzinga
04:55AM	GenMark Soaring In Pre-Market On 118% Revenue Explosion SmarterAnalyst
Jul-07-20 04:05PM	GenMark Diagnostics Provides Preliminary Financial and Operational Results for Second Quarter 2020 GlobeNewswire
Jun-29-20 07:00AM	GenMark Diagnostics Announces Commercial Launch of its ePlex® Respiratory Pathogen Panel 2 (RP2) GlobeNewswire
Jun-28-20 04:07PM	Hedge Funds Cashing Out Of GenMark Diagnostics, Inc (GNMK) Insider Monkey
Jun-27-20 01:15PM	Heres a hedge fund strategy that just might work for you MarketWatch
Jun-19-20 12:16PM	Will GenMark Diagnostics Continue to Surge Higher? Zacks +6.34%
12:00PM	GenMark Diagnostics (GNMK) Upgraded to Strong Buy: Here's What You Should Know Zacks
Jun-16-20 08:00AM	GenMark Diagnostics Chosen as Primary Provider of Rapid Diagnostic Testing for Vidant Health GlobeNewswire
Jun-12-20 07:55PM	Edited Transcript of GNMK earnings conference call or presentation 4-May-20 8:30pm GMT Thomson Reuters StreetEvents +6.04%
Jun-10-20 08:35AM	Soliton (SOLY) Catches Eye: Stock Jumps 5.2% Zacks +6.85%
08:29AM	TransEnterix (TRXC) Catches Eye: Stock Jumps 6.3% Zacks
May-28-20 10:30AM	GenMark Diagnostics Sees Hammer Chart Pattern: Time to Buy? Zacks
May-27-20 04:05PM	GenMark Diagnostics to Participate in Upcoming Investor Conferences GlobeNewswire
May-26-20 08:49AM	Is GenMark Diagnostics (GNMK) Stock a Solid Choice Right Now? Zacks
May-14-20 11:16AM	Will GenMark Diagnostics' Stock Keep Rising? Motley Fool
May-11-20 04:01PM	GenMark Diagnostics Announces Closing of $80 Million Public Offering of Common Stock, Including Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire +6.27%
May-08-20 10:52AM	Top Ranked Momentum Stocks to Buy for May 8th Zacks -6.85%
May-07-20 10:39AM	GenMark Diagnostics: P/E Ratio Insights Benzinga +32.23%
May-06-20 10:59PM	GenMark Prices Public Offering of Common Stock GlobeNewswire -14.64%
04:01PM	GenMark Commences Public Offering of Common Stock GlobeNewswire
May-05-20 08:00AM	The Daily Biotech Pulse: Bio-Rad's Coronavirus Test Gets EUA, Beat-And-Raise Quarter From GenMark, Adverum's Positive Gene Therapy Readout Benzinga
04:01AM	GenMark Diagnostics Inc (GNMK) Q1 2020 Earnings Call Transcript Motley Fool
May-04-20 06:55PM	GenMark Diagnostics (GNMK) Reports Q1 Loss, Tops Revenue Estimates Zacks -6.83%
04:05PM	GenMark Diagnostics Reports First Quarter 2020 Results GlobeNewswire
04:03PM	GenMark Diagnostics Announces Scott Mendel Appointed CEO GlobeNewswire
Apr-27-20 12:31PM	GenMark Diagnostics (GNMK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Apr-24-20 10:50AM	3 Monster Growth Stocks Gearing up for Gains TipRanks +5.40%
Apr-23-20 10:01AM	Implied Volatility Surging for GenMark (GNMK) Stock Options Zacks +18.34%
Apr-22-20 04:05PM	GenMark Diagnostics to Report First Quarter 2020 Financial Results on May 4, 2020 GlobeNewswire +6.26%
Apr-20-20 07:54AM	A Look At The Fair Value Of GenMark Diagnostics, Inc. (NASDAQ:GNMK) Simply Wall St. +6.72%
Apr-08-20 04:26PM	Covid Report: Small Biotech Surges On Plan To Test Vaccine In May Investor's Business Daily +34.22%
07:53AM	The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO Benzinga
02:45AM	GenMark Sees 80% Q1 Revenue Boost on Covid-19 Tests SmarterAnalyst
Apr-07-20 04:03PM	GenMark Diagnostics Provides Preliminary Financial and Operational Results for First Quarter 2020 and Increases 2020 Revenue Guidance GlobeNewswire
Mar-23-20 07:45PM	GenMark Awarded BARDA Grant for the Development of ePlex® RP2 Panel GlobeNewswire -20.90%
09:31AM	Is the Options Market Predicting a Spike in GenMark (GNMK) Stock? Zacks
09:30AM	Company News for Mar 23, 2020 Zacks
Mar-22-20 08:19AM	3 Coronavirus Stocks with Over 60% Upside TipRanks
Mar-19-20 09:23PM	GenMark Receives FDA Emergency Use Authorization for its ePlex® SARS-CoV-2 Test GlobeNewswire +16.01%
Mar-11-20 12:47PM	Edited Transcript of GNMK earnings conference call or presentation 2-Mar-20 9:30pm GMT Thomson Reuters StreetEvents +14.11%
10:44AM	GenMark's stock rises 8% as it seeks authorization to market its COVID-19 test MarketWatch
10:18AM	GenMark Diagnostics Submits Test for Coronavirus to FDA TheStreet.com
09:54AM	The Zacks Analyst Blog Highlights: Co-Diagnostics, GenMark Diagnostics, OPKO Health and Inovio Pharmaceuticals Zacks
09:06AM	GenMark Diagnostics Files For Emergency Use Authorization For COVID-19 Test Benzinga
08:26AM	Benzinga Pro's Top 5 Stocks To Watch For Wed., Mar. 11, 2020: TDOC, GNMK, HLT, MEET, AYTU Benzinga
08:00AM	GenMark Diagnostics Announces Submission of Emergency Use Authorization for its ePlex® SARS-CoV-2 Test GlobeNewswire
Mar-04-20 08:04AM	Benzinga Pro's Top 5 Stocks To Watch For Wed., Mar. 4, 2020: JWN, VIR, CMG, AHPI, GNMK Benzinga +6.65%
Mar-02-20 05:35PM	GenMark Diagnostics (GNMK) Reports Q4 Loss, Tops Revenue Estimates Zacks
04:05PM	GenMark Diagnostics Reports Fourth Quarter and Full Year 2019 Results GlobeNewswire
04:03PM	GenMark Diagnostics Announces Global Shipments of ePlex® RUO Test Kits Designed for SARS-CoV-2 Detection GlobeNewswire
Feb-25-20 08:35AM	Zacks.com featured highlights include: Calavo Growers, eBay, GenMark Diagnostics, Telenav and Heico Zacks
Feb-24-20 12:30PM	GenMark Diagnostics (GNMK) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks -6.13%
09:28AM	Go Beyond Bargain Hunting: 5 Stocks With Rising P/E Zacks
Feb-18-20 04:05PM	GenMark Diagnostics to Participate in the Cowen Health Care Conference GlobeNewswire
Feb-17-20 05:57AM	GenMark Diagnostics Enters Oversold Territory Zacks
Feb-10-20 05:30PM	GenMark Diagnostics Schedules Fourth Quarter and Full Year 2019 Financial Results Conference Call for March 2, 2020 GlobeNewswire
05:15PM	GenMark Diagnostics Announces CEO and Chairman Transition GlobeNewswire

GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular panels based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results. The company offers XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents to support a range of molecular tests with a workstation and disposable test cartridges. It also provides diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, thrombophilia risk test, a warfarin sensitivity test, and hepatitis C virus genotyping test and associated custom manufactured reagents, as well as 2C19 genotyping test. The company sells its products through direct sales and technically specialized service organization in the United States and Europe. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Maderazo Alan Baer	VP, Qual, Reg, & Clin Affairs	Feb 25	Sale	19.16	266	5,097	278,253	Feb 25 06:33 PM
Maderazo Alan Baer	VP, Qual, Reg, & Clin Affairs	Feb 24	Sale	19.12	163	3,117	280,263	Feb 24 06:04 PM
Gleeson Michael	SVP, Corp. Accounts	Feb 24	Sale	19.12	2,463	47,093	410,493	Feb 25 06:32 PM
Shaw Christine	VP, Assay Development	Feb 24	Sale	19.12	259	4,952	105,621	Feb 25 06:32 PM
Gleeson Michael	SVP, Corp. Accounts	Feb 23	Sale	19.35	1,432	27,709	412,956	Feb 25 06:32 PM
Shaw Christine	VP, Assay Development	Feb 23	Sale	19.35	166	3,212	105,880	Feb 25 06:32 PM
Maderazo Alan Baer	VP, Qual, Reg, & Clin Affairs	Feb 22	Sale	20.36	290	5,904	281,496	Feb 22 07:02 PM
Winkler Sarah Hollis	VP, Human Resources	Feb 19	Sale	21.80	654	14,257	158,683	Feb 22 07:04 PM
Gleeson Michael	SVP, Corp. Accounts	Feb 19	Sale	21.80	2,340	51,012	414,388	Feb 22 07:03 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Feb 18	Sale	21.68	500	10,840	214,097	Feb 22 06:59 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Feb 11	Sale	22.00	10,000	220,000	214,597	Feb 16 05:17 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Feb 04	Sale	14.69	500	7,345	224,597	Feb 08 05:10 PM
Winkler Sarah Hollis	VP, Human Resources	Jan 27	Sale	14.06	783	11,009	140,587	Jan 29 05:14 PM
Shaw Christine	VP, Assay Development	Jan 27	Sale	14.06	81	1,139	79,796	Jan 29 05:15 PM
Harkins Michael John	SVP, Sales	Jan 27	Sale	14.06	1,117	15,705	144,742	Jan 29 05:14 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Jan 27	Sale	14.06	322	4,527	225,097	Jan 29 05:16 PM
O'Brien Scott Alexander	SVP, Global Mktg & Int'l Sales	Jan 27	Sale	14.06	180	2,531	144,965	Jan 29 05:15 PM
Maderazo Alan Baer	VP, Qual, Reg, & Clin Affairs	Jan 26	Sale	15.19	6,214	94,391	261,106	Jan 29 05:16 PM
Mendel Scott	President & CEO	Jan 25	Sale	14.23	64,975	924,594	478,028	Jan 25 08:35 PM
Harkins Michael John	SVP, Sales	Jan 25	Sale	14.22	7,338	104,346	145,859	Jan 25 08:36 PM
Stier Eric	SVP & General Counsel	Jan 25	Sale	14.22	29,658	421,737	277,619	Jan 25 08:35 PM
Maderazo Alan Baer	VP, Qual, Reg, & Clin Affairs	Jan 25	Sale	14.22	23,764	337,924	267,320	Jan 25 08:35 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Jan 25	Sale	14.23	20,953	298,161	225,419	Jan 25 08:37 PM
O'Brien Scott Alexander	SVP, Global Mktg & Int'l Sales	Jan 25	Sale	14.23	6,458	91,897	145,145	Jan 25 08:36 PM
Winkler Sarah Hollis	VP, Human Resources	Jan 25	Sale	14.22	10,317	146,708	141,370	Jan 25 08:36 PM
Ek John Frederick	Chief Financial Officer	Jan 25	Sale	14.24	18,475	263,084	210,258	Jan 25 08:36 PM
Gleeson Michael	SVP, Corp. Accounts	Jan 25	Sale	14.22	33,027	469,644	397,978	Jan 25 08:37 PM
Mendel Scott	President & CEO	Jan 21	Option Exercise	0.00	146,172	0	543,002	Jan 21 08:09 PM
Maderazo Alan Baer	VP, Qual, Reg, & Clin Affairs	Jan 21	Option Exercise	0.00	65,185	0	291,084	Jan 22 06:25 PM
Harkins Michael John	SVP, Sales	Jan 21	Option Exercise	0.00	19,166	0	153,197	Jan 25 08:36 PM
Stier Eric	SVP & General Counsel	Jan 21	Option Exercise	0.00	77,240	0	307,277	Jan 25 08:35 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Jan 21	Option Exercise	0.00	56,864	0	246,372	Jan 25 08:37 PM
O'Brien Scott Alexander	SVP, Global Mktg & Int'l Sales	Jan 21	Option Exercise	0.00	16,666	0	151,603	Jan 25 08:36 PM
Winkler Sarah Hollis	VP, Human Resources	Jan 21	Option Exercise	0.00	27,511	0	151,687	Jan 25 08:36 PM
Ek John Frederick	Chief Financial Officer	Jan 21	Option Exercise	0.00	50,449	0	228,733	Jan 25 08:36 PM
Gleeson Michael	SVP, Corp. Accounts	Jan 21	Option Exercise	0.00	83,836	0	431,005	Jan 25 08:37 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Jan 21	Sale	14.93	500	7,465	189,508	Jan 25 08:37 PM
Maderazo Alan Baer	VP, Qual, Reg, & Clin Affairs	Jan 20	Sale	15.00	5,000	75,000	225,899	Jan 22 06:25 PM
Mendel Scott	President & CEO	Jan 19	Sale	14.54	50,000	727,000	115,491	Jan 21 08:09 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Jan 07	Option Exercise	11.96	31,500	376,665	222,485	Jan 08 06:01 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Jan 07	Sale	16.99	32,477	551,784	190,008	Jan 08 06:01 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Jan 06	Sale	16.00	16,823	269,168	190,985	Jan 08 06:01 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Dec 24	Sale	15.00	500	7,500	207,808	Dec 29 06:32 PM
Maderazo Alan Baer	VP, Qual, Reg, & Clin Affairs	Dec 21	Sale	15.00	15,000	225,000	230,899	Dec 22 05:42 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Dec 10	Sale	12.79	500	6,395	208,308	Dec 11 05:51 PM
O'Brien Scott Alexander	SVP, Global Mktg & Int'l Sales	Dec 07	Sale	13.97	742	10,366	134,937	Dec 09 05:24 PM
Shaw Christine	VP, Assay Development	Dec 07	Sale	13.97	274	3,828	79,877	Dec 09 05:24 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Nov 27	Sale	12.42	500	6,210	208,186	Dec 01 05:48 PM
Maderazo Alan Baer	VP, Qual, Reg, & Clin Affairs	Nov 25	Sale	12.72	552	7,021	245,899	Nov 25 05:28 PM
Ek John Frederick	Chief Financial Officer	Nov 24	Sale	13.17	1,418	18,675	178,284	Nov 25 05:30 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Nov 24	Sale	13.17	1,132	14,908	208,686	Nov 25 05:29 PM
Shaw Christine	VP, Assay Development	Nov 24	Sale	13.17	355	4,675	79,291	Nov 25 05:29 PM
Mendel Scott	President & CEO	Nov 24	Sale	13.17	5,190	68,352	396,830	Nov 25 05:29 PM
Stier Eric	SVP & General Counsel	Nov 24	Sale	13.17	2,512	33,083	230,037	Nov 25 05:28 PM
Gleeson Michael	SVP, Corp. Accounts	Nov 24	Sale	13.17	3,234	42,592	347,169	Nov 25 05:28 PM
O'Brien Scott Alexander	SVP, Global Mktg & Int'l Sales	Nov 24	Sale	13.17	1,144	15,066	135,679	Nov 25 05:29 PM
Maderazo Alan Baer	VP, Qual, Reg, & Clin Affairs	Nov 24	Sale	13.17	1,994	26,261	246,451	Nov 24 07:53 PM
Maderazo Alan Baer	VP, Qual, Reg, & Clin Affairs	Nov 20	Sale	13.01	366	4,762	248,445	Nov 24 07:53 PM
Mendel Scott	President & CEO	Nov 19	Sale	13.85	3,987	55,220	402,020	Nov 20 06:09 PM
Stier Eric	SVP & General Counsel	Nov 19	Sale	13.85	1,555	21,537	232,549	Nov 20 06:09 PM
Maderazo Alan Baer	VP, Qual, Reg, & Clin Affairs	Nov 19	Sale	13.85	1,310	18,144	248,811	Nov 20 06:10 PM
Ek John Frederick	Chief Financial Officer	Nov 19	Sale	13.85	1,637	22,672	179,702	Nov 20 06:10 PM
Gleeson Michael	SVP, Corp. Accounts	Nov 19	Sale	13.85	1,637	22,672	350,403	Nov 20 06:10 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Nov 19	Sale	13.85	1,146	15,872	209,818	Nov 20 06:08 PM
Winkler Sarah Hollis	VP, Human Resources	Nov 19	Sale	13.85	656	9,086	124,176	Nov 20 06:09 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Nov 12	Sale	13.68	500	6,840	210,964	Nov 13 05:34 PM
Stier Eric	SVP & General Counsel	Nov 11	Sale	12.77	59,293	757,172	234,104	Nov 13 05:35 PM
O'Brien Scott Alexander	SVP, Global Mktg & Int'l Sales	Nov 03	Sale	12.73	212	2,699	136,823	Nov 04 06:46 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Oct 29	Sale	11.32	500	5,660	211,464	Oct 29 06:07 PM
Winkler Sarah Hollis	VP, Human Resources	Oct 27	Sale	11.34	765	8,675	124,832	Oct 29 06:06 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Oct 27	Sale	11.34	220	2,495	211,964	Oct 29 06:07 PM
Shaw Christine	VP, Assay Development	Oct 27	Sale	11.34	68	771	79,646	Oct 29 06:09 PM
O'Brien Scott Alexander	SVP, Global Mktg & Int'l Sales	Oct 27	Sale	11.34	177	2,007	137,035	Oct 29 06:10 PM
Harkins Michael John	SVP, Sales	Oct 27	Sale	11.34	1,092	12,383	132,982	Oct 29 06:12 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Oct 15	Sale	11.83	500	5,915	209,765	Oct 16 05:01 PM
Maderazo Alan Baer	VP, Qual, Reg, & Clin Affairs	Oct 07	Option Exercise	12.76	58,680	748,786	319,870	Oct 09 06:35 PM
Maderazo Alan Baer	VP, Qual, Reg, & Clin Affairs	Oct 07	Sale	15.00	69,749	1,046,235	250,121	Oct 09 06:35 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Oct 01	Sale	14.46	500	7,230	210,265	Oct 02 07:37 PM
Ek John Frederick	Chief Financial Officer	Sep 22	Sale	13.82	41,196	569,329	181,339	Sep 24 05:58 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Sep 17	Sale	12.72	500	6,360	210,765	Sep 18 05:39 PM
Ek John Frederick	Chief Financial Officer	Sep 16	Sale	12.98	5,723	74,285	222,535	Sep 18 05:40 PM
O'Brien Scott Alexander	SVP, Global Mktg & Int'l Sales	Sep 08	Sale	11.02	770	8,485	137,212	Sep 10 06:16 PM
Shaw Christine	VP, Assay Development	Sep 08	Sale	11.02	285	3,141	79,714	Sep 10 06:14 PM
Mitchell Brian Andrew	SVP, Operations	Sep 08	Sale	11.02	4,000	44,080	166,651	Sep 10 05:45 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Sep 03	Sale	12.20	500	6,100	211,265	Sep 04 05:44 PM
Maderazo Alan Baer	VP, Qual, Reg, & Clin Affairs	Aug 27	Sale	13.10	891	11,672	261,190	Aug 28 05:54 PM
Mendel Scott	President & CEO	Aug 26	Sale	15.02	50,000	751,000	81,690	Aug 28 05:53 PM
Mitchell Brian Andrew	SVP, Operations	Aug 26	Sale	14.74	3,464	51,059	170,651	Aug 26 06:32 PM
Mitchell Brian Andrew	SVP, Operations	Aug 25	Sale	14.14	2,083	29,454	174,115	Aug 26 06:32 PM
Mendel Scott	President & CEO	Aug 25	Sale	14.14	4,532	64,082	489,808	Aug 26 06:30 PM
Stier Eric	SVP & General Counsel	Aug 25	Sale	14.14	2,684	37,952	293,397	Aug 26 06:29 PM
Maderazo Alan Baer	VP, Qual, Reg, & Clin Affairs	Aug 25	Sale	14.14	2,130	30,118	262,081	Aug 26 06:28 PM
Jensen Tyler	SVP, Engineering and Tech Dev	Aug 25	Sale	14.14	1,211	17,124	211,765	Aug 26 06:27 PM
Ek John Frederick	Chief Financial Officer	Aug 25	Sale	14.14	1,515	21,422	228,258	Aug 26 06:18 PM
Shaw Christine	VP, Assay Development	Aug 25	Sale	14.14	379	5,359	79,999	Aug 26 06:17 PM
Gleeson Michael	SVP, Corp. Accounts	Aug 25	Sale	14.14	2,904	41,063	352,040	Aug 26 06:15 PM
O'Brien Scott Alexander	SVP, Global Mktg & Int'l Sales	Aug 25	Sale	14.14	1,223	17,293	137,982	Aug 26 06:14 PM
Mitchell Brian Andrew	SVP, Operations	Aug 21	Sale	15.62	2,997	46,813	176,198	Aug 24 06:11 PM
Mendel Scott	President & CEO	Aug 20	Sale	15.41	2,988	46,045	494,340	Aug 24 06:13 PM
Maderazo Alan Baer	VP, Qual, Reg, & Clin Affairs	Aug 20	Sale	15.41	1,353	20,850	264,211	Aug 24 06:12 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience